Ryvu Therapeutics SA
WSE:RVU

Watchlist Manager

Ryvu Therapeutics SA

WSE:RVU

Watchlist

Discount Rate

Price: 54.1 PLN -1.64% Market Closed

Market Cap: 1.3B PLN

Have any thoughts about
Ryvu Therapeutics SA?

Write Note

Write Note Create Alert Ask AI

Add Note Why Create Notes?

Capture your thoughts

Note Buy Sell Hold Pass

US	Johnson & Johnson NYSE:JNJ	Pharmaceuticals
US	Berkshire Hathaway Inc NYSE:BRK.A	Financial Services
US	Bank of America Corp NYSE:BAC	Banking
US	Mastercard Inc NYSE:MA	Technology
US	Abbvie Inc NYSE:ABBV	Biotechnology
US	Pfizer Inc NYSE:PFE	Pharmaceuticals
US	Palantir Technologies Inc NYSE:PLTR	Technology
US	Nike Inc NYSE:NKE	Textiles, Apparel & Luxury Goods
US	Visa Inc NYSE:V	Technology
CN	Alibaba Group Holding Ltd NYSE:BABA	Retail
US	3M Co NYSE:MMM	Industrial Conglomerates
US	JPMorgan Chase & Co NYSE:JPM	Banking
US	Coca-Cola Co NYSE:KO	Beverages
US	Realty Income Corp NYSE:O	Real Estate
US	Walt Disney Co NYSE:DIS	Media
US	PayPal Holdings Inc NASDAQ:PYPL	Technology

Add Price Alert

Price Target:

Last Price: 54.1 PLN

We'll email you a reminder when the closing price reaches USD.

If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Peter Lynch

Track and Analyze Performance

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.

Continuous Learning and Adaptation

Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.

Boost Decision Confidence

With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.

Why create notes?

Back

Delete Note

Do you really want to delete this note?
This action cannot be undone.

Remove price alert for reaching

Delete

Cancel

RVU Alert

Ryvu Therapeutics SA

54.1

-0.9 (-1.64%)

52 Week Range	48.6 72.1
Price Target

We'll email you a reminder when the closing price reaches PLN.

Save Alert

Choose the stock you wish to monitor with a price alert.

	Johnson & Johnson NYSE:JNJ	US
	Berkshire Hathaway Inc NYSE:BRK.A	US
	Bank of America Corp NYSE:BAC	US
	Mastercard Inc NYSE:MA	US
	Abbvie Inc NYSE:ABBV	US
	Pfizer Inc NYSE:PFE	US
	Palantir Technologies Inc NYSE:PLTR	US
	Nike Inc NYSE:NKE	US
	Visa Inc NYSE:V	US
	Alibaba Group Holding Ltd NYSE:BABA	CN
	3M Co NYSE:MMM	US
	JPMorgan Chase & Co NYSE:JPM	US
	Coca-Cola Co NYSE:KO	US
	Realty Income Corp NYSE:O	US
	Walt Disney Co NYSE:DIS	US
	PayPal Holdings Inc NASDAQ:PYPL	US

Delete Alert

This alert will be permanently deleted.

Remove note

Delete

Cancel

Ask me anything about

Ryvu Therapeutics SA

What unique competitive advantages
does Ryvu Therapeutics SA hold over its rivals?

What risks and challenges
does Ryvu Therapeutics SA face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Provide an overview of the primary business activities
of Ryvu Therapeutics SA.

What unique competitive advantages
does Ryvu Therapeutics SA hold over its rivals?

What risks and challenges
does Ryvu Therapeutics SA face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Ryvu Therapeutics SA.

Provide P/S
for Ryvu Therapeutics SA.

Provide P/E
for Ryvu Therapeutics SA.

Provide P/OCF
for Ryvu Therapeutics SA.

Provide P/FCFE
for Ryvu Therapeutics SA.

Provide P/B
for Ryvu Therapeutics SA.

Provide EV/S
for Ryvu Therapeutics SA.

Provide EV/GP
for Ryvu Therapeutics SA.

Provide EV/EBITDA
for Ryvu Therapeutics SA.

Provide EV/EBIT
for Ryvu Therapeutics SA.

Provide EV/OCF
for Ryvu Therapeutics SA.

Provide EV/FCFF
for Ryvu Therapeutics SA.

Provide EV/IC
for Ryvu Therapeutics SA.

Show me price targets
for Ryvu Therapeutics SA made by professional analysts.

What are the Revenue projections
for Ryvu Therapeutics SA?

How accurate were the past Revenue estimates
for Ryvu Therapeutics SA?

What are the Net Income projections
for Ryvu Therapeutics SA?

How accurate were the past Net Income estimates
for Ryvu Therapeutics SA?

What are the EPS projections
for Ryvu Therapeutics SA?

How accurate were the past EPS estimates
for Ryvu Therapeutics SA?

What are the EBIT projections
for Ryvu Therapeutics SA?

How accurate were the past EBIT estimates
for Ryvu Therapeutics SA?

Compare the revenue forecasts
for Ryvu Therapeutics SA with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Ryvu Therapeutics SA and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Ryvu Therapeutics SA against its competitors.

Analyze the profit margins
(gross, operating, and net) of Ryvu Therapeutics SA compared to its peers.

Compare the P/E ratios
of Ryvu Therapeutics SA against its peers.

Discuss the investment returns and shareholder value creation
comparing Ryvu Therapeutics SA with its peers.

Analyze the financial leverage
of Ryvu Therapeutics SA compared to its main competitors.

Show all profitability ratios
for Ryvu Therapeutics SA.

Provide ROE
for Ryvu Therapeutics SA.

Provide ROA
for Ryvu Therapeutics SA.

Provide ROIC
for Ryvu Therapeutics SA.

Provide ROCE
for Ryvu Therapeutics SA.

Provide Gross Margin
for Ryvu Therapeutics SA.

Provide Operating Margin
for Ryvu Therapeutics SA.

Provide Net Margin
for Ryvu Therapeutics SA.

Provide FCF Margin
for Ryvu Therapeutics SA.

Show all solvency ratios
for Ryvu Therapeutics SA.

Provide D/E Ratio
for Ryvu Therapeutics SA.

Provide D/A Ratio
for Ryvu Therapeutics SA.

Provide Interest Coverage Ratio
for Ryvu Therapeutics SA.

Provide Altman Z-Score Ratio
for Ryvu Therapeutics SA.

Provide Quick Ratio
for Ryvu Therapeutics SA.

Provide Current Ratio
for Ryvu Therapeutics SA.

Provide Cash Ratio
for Ryvu Therapeutics SA.

What is the historical Revenue growth
over the last 5 years for Ryvu Therapeutics SA?

What is the historical Net Income growth
over the last 5 years for Ryvu Therapeutics SA?

What is the current Free Cash Flow
of Ryvu Therapeutics SA?

Discuss the annual earnings per share (EPS)
trend over the past five years for Ryvu Therapeutics SA.

RVU

Cash Flow Statement

Cash from Financing Activities

Ryvu Therapeutics SA
Cash from Financing Activities

Last Value

3-Years 3-Y CAGR

5-Years 5-Y CAGR

10-Years 10-Y CAGR

Quarterly

Annual

TTM

Adjust for Inflation

Ryvu Therapeutics SA
Cash from Financing Activities Peer Comparison

Comparables:

IGN

MDB

SLV

Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors

Company		Cash from Financing Activities	CAGR 3Y	CAGR 5Y	CAGR 10Y
R	Ryvu Therapeutics SA WSE:RVU	Cash from Financing Activities zł33.2m	CAGR 3-Years -37%	CAGR 5-Years 15%	CAGR 10-Years N/A
I	Inno-Gene SA WSE:IGN	Cash from Financing Activities zł895k	CAGR 3-Years -29%	CAGR 5-Years 38%	CAGR 10-Years 33%
M	Medicofarma Biotech SA WSE:MDB	Cash from Financing Activities zł596.7k	CAGR 3-Years N/A	CAGR 5-Years 127%	CAGR 10-Years N/A
S	Selvita SA WSE:SLV	Cash from Financing Activities -zł42.4m	CAGR 3-Years N/A	CAGR 5-Years N/A	CAGR 10-Years N/A

What is Ryvu Therapeutics SA's Cash from Financing Activities?

Cash from Financing Activities
33.2m PLN

Based on the financial report for Mar 31, 2024, Ryvu Therapeutics SA's Cash from Financing Activities amounts to 33.2m PLN.

What is Ryvu Therapeutics SA's Cash from Financing Activities growth rate?

Cash from Financing Activities CAGR 5Y
15%

Over the last year, the Cash from Financing Activities growth was -86%. The average annual Cash from Financing Activities growth rates for Ryvu Therapeutics SA have been -37% over the past three years , 15% over the past five years .

Ryvu Therapeutics SA
WSE:RVU

Ryvu Therapeutics SA
Cash from Financing Activities

Ryvu Therapeutics SA
Cash from Financing Activities Peer Comparison

Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors

See Also

What is Ryvu Therapeutics SA's Cash from Financing Activities?

Cash from Financing Activities
33.2m PLN

What is Ryvu Therapeutics SA's Cash from Financing Activities growth rate?

Cash from Financing Activities CAGR 5Y
15%

Company

Help

Tools

Stocks

Ryvu Therapeutics SA WSE:RVU

Ryvu Therapeutics SA Cash from Financing Activities

Ryvu Therapeutics SA Cash from Financing Activities Peer Comparison

Competitive Cash from Financing Activities Analysis Latest Figures & CAGR of Competitors

See Also

What is Ryvu Therapeutics SA's Cash from Financing Activities? Cash from Financing Activities 33.2m PLN

What is Ryvu Therapeutics SA's Cash from Financing Activities growth rate? Cash from Financing Activities CAGR 5Y 15%

Company

Help

Tools

Stocks

Ryvu Therapeutics SA
WSE:RVU

Ryvu Therapeutics SA
Cash from Financing Activities

Ryvu Therapeutics SA
Cash from Financing Activities Peer Comparison

Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors

What is Ryvu Therapeutics SA's Cash from Financing Activities?

Cash from Financing Activities
33.2m PLN

What is Ryvu Therapeutics SA's Cash from Financing Activities growth rate?

Cash from Financing Activities CAGR 5Y
15%